Skip to main content
Tech.euFundingExplorerBeta

Adaptyv Biosystems

Project specialising in antibody screening

Adaptyv Biosystems has raised €37M across 3 funding rounds from 15 investors, most recently a Series A round in Aug 2026. Based in Switzerland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€37M
€36,759,427
Funding rounds
3
Investors
15
distinct backers
Active since
2021-08
latest 2026-08

Funding by year

EUR raised per year · 2026 YTD
Adaptyv Biosystems — funding by year — interactive chart.
Data table
Adaptyv Biosystems — funding by year
2021€93k
2022€2.4M
2026€34M

Signals

High confidence
Raise-next likelihood22
base rate 44% for Series A
  • ▼ Raised very recently
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood24
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 5y since founding (typical exit age)
  • ▲ Recently backed by strong-exit-track investors

Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds

Similar companies

same sector or country

Global coverage: FundingData